To better understand the molecular signatures between Dll1+ and Dll1− tumor cells in breast cancer, we performed RNA-seq analysis using Dll1+ and Dll1− tumor cells from both PyMT-Dll1mCh and PyMT-Dll1GFP tumors (Supplementary Fig. 5a). The gene discussed is DLL1; the disease is breast carcinoma.